I. Behrens et al., Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells, PHARM RES, 18(8), 2001, pp. 1138-1145
Purpose. A new mucus-secreting in vitro drug absorption model based on mono
layers of goblet-cell like sub-clones of the human colon carcinoma cell lin
e HT29 obtained by methotrexate (MTX) treatment was investigated.
Methods. Twelve sub-clones were isolated and characterized by light microsc
opy (LM), transelectron microscopy (TEM), confocal laser scanning microscop
y (CLSM), transepithelial electrical resistance (TEER) and the transport of
a paracellular marker FITC-Dextran (Mw 4400) (FD-4).
Results. Significant differences of microscopical appearance, TEER-values a
nd permeability of FD-4 between the sub-clones were evident. However, two o
f them, namely MTX-DI and MTX-E12, formed tight confluent monolayers with a
thick mucus-layer on the apical surface. They were used to compare the app
arent permeability coefficient (P-app) of a series of lipophilic drugs, whi
ch should be affected by the mucus-layer, namely barbiturates (barbituric a
cid, barbital, phenobarbital, methylphenobarbital and heptabarbital) and te
stosterone, as a reference, to mucus-free Caco-2 cells. The permeability of
drugs with a partition coefficient (log P) > I was decreased in the mucus-
producing cell lines. Testosterone, the most lipophilic compound, showed a
decrease of up to 43%.
Conclusions. We demonstrated that the mucus layer is a significant barrier
to drug absorption for lipophilic drugs. In conclusion, our model may serve
as a suitable in-vitro cell culture model to study the influence of the mu
cus layer on drug diffusion.